{
    "patient": {
        "Name": "Sarah Hall",
        "DateOfBirth": "1968-05-23",
        "Sex": "Male",
        "Diagnosis": "Hodgkin lymphoma",
        "BodyPart": "Lymphoma",
        "Physician": "Dr. Paul Thompson",
        "TreatingInstitution": "Perez Group"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Lymphoma",
            "CollectedDate": "2024-01-01",
            "ReceivedDate": "2024-01-01",
            "TumorPercentage": "72%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2024-01-06",
            "ReceivedDate": "2024-01-09"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "MYD88",
                "DNA Alteration": "c.794T>C",
                "GeneMutation": "p.L265P Nonsense-LOF",
                "VariantAlleleFraction": "9.58%"
            },
            {
                "Gene": "BRCA2",
                "DNA Alteration": "c.5946delT",
                "GeneMutation": "p.S1982Rfs*22 Stopgain-LOF",
                "VariantAlleleFraction": "15.84%"
            },
            {
                "Gene": "MYCN",
                "DNA Alteration": "c.131C>T",
                "GeneMutation": "p.P44L Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "19.83%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "JAK3",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.L857P Frameshift-GOF",
                "VariantAlleleFraction": "13.22%"
            },
            {
                "Gene": "ABL1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.L857P Frameshift-LOF",
                "VariantAlleleFraction": "11.9%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "HDAC1",
            "PTPN11",
            "ERBB2"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "26 m/Mb",
            "Tmbpercentile": "50%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}